Paxlovid has been free so far. Next year, sticker shock awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Paxlovid, the antiviral pill produced by Pfizer, has helped prevent many people infected with COVID-19 from being hospitalized or dying. But the U.S. government plans to stop footing the bill in 2023, and millions of people who are at the highest risk of severe illness and are least able to afford the drug – the uninsured and seniors – may have to pay the full price.
THE HAGUE, Dec 10, 2022 (BSS/AFP) - The EU's drug watchdog warned on Friday that antibody treatments for Covid are
European Medicines Agency says they do not neutralise the variants, which are expected to become the dominant strains in the coming weeks
Millions of those least able to afford the drug and at the highest risk of severe illness may have to pay full price.